Comment & Response |

Drug Discount Program—Reply

Rena M. Conti, PhD1
[+] Author Affiliations
1Department of Pediatrics, University of Chicago, Chicago, Illinois
JAMA. 2013;310(15):1627. doi:10.1001/jama.2013.276770.
Text Size: A A A
Published online


In Reply Neither Messrs Slafsky and Davis nor Drs Swain and Ward address the merits of the principle espoused in the Viewpoint, which is that when drugs are provided at a discount to institutions caring for cancer patients, those discounts should be passed on to the patients and their insurers. Currently, 340B hospitals get drugs at a discount, yet bill patients and insurers as if the drugs were obtained at full price.

We proposed 2 possible improvements: either scale down the program and limit drug discounts to patients who are poor or uninsured or keep the program at its current scale and pass on the savings to patients and their insurers if they are treated at a 340B facility and receive drugs that were purchased at a discount.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




October 16, 2013
Sandra M. Swain, MD; Jeffery C. Ward, MD
1Washington Cancer Institute, Medstar Washington Hospital Center, Washington, DC
2Medical Oncology, Swedish Cancer Institute Edmonds, Edmonds, Washington
JAMA. 2013;310(15):1626-1627. doi:10.1001/jama.2013.276737.
October 16, 2013
Ted Slafsky, MPP; Jeff Davis, JD
1Safety Net Hospitals for Pharmaceutical Access, Washington, DC
JAMA. 2013;310(15):1626-1627. doi:10.1001/jama.2013.276758.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Related Topics